Clinical Trial Update: [F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for [F-18] Fluorothymidine PET/CT imaging in pelvic cancers has completed; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Neoplasms
• Uterine Cervical Neoplasms

Drugs mentioned

• [F-18] Fluorothymidine PET/CT imaging (fluorothymidine)

Snippet

Sponsor: John M. Buatti | Conditions: Uterine Cervical Neoplasms, Endometrial Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2017-09-05